1136279

Albireo Pharma, Inc. — FEI 3014733942

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 16, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cambridge, MA (United States)

Additional Details

Sponsor, Contract Research Organization